Allspring Global Investments
ORIC icon

Allspring Global Investments’s Oric Pharmaceuticals ORIC Stock Holding History

Allspring Global Investments’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-3,414
Closed -$20.7K – 2586
2023
Q3 		$20.7K Buy
+3,414
New +$28K ﹤0.01% 2503
2022
Q3 		– Sell
-65,716
Closed -$294K – 2933
2022
Q2 		$294K Sell
65,716
-916,438
-93% -$3.66M ﹤0.01% 1710
2022
Q1 		$5.24M Sell
982,154
-18,045
-2% -$163K 0.01% 1126
2021
Q4 		$14.7M Buy
+1,000,199
New +$15.6M 0.02% 807

Other funds holding ORIC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $74.1B AUM 71.18% 1-Year Est. Return
CG
Column Group San Francisco, California $88.1M AUM 148.03% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

Allspring Global Investments's ORIC Position: Q4 2023 in Review

Allspring Global Investments sold out of Oric Pharmaceuticals (ORIC) in Q4 2023, closing a stake of 3,414 shares — an estimated $20.7K sold.

Allspring Global Investments first reported a position in ORIC in Q4 2021 and held it in 4 quarters. The position peaked at $14.7M in Q4 2021. 92 funds tracked by Wall St. Rank hold ORIC as of Q4 2023.

  • Allspring Global Investments reported no remaining Oric Pharmaceuticals position as of Q4 2023 after selling out during the quarter.
  • Allspring Global Investments sold 3,414 Oric Pharmaceuticals shares in Q4 2023, an estimated $20.7K.
  • Allspring Global Investments first reported a position in Oric Pharmaceuticals in Q4 2021 and held it in 4 quarters.
  • Allspring Global Investments's Oric Pharmaceuticals position peaked at $14.7M in Q4 2021.
  • 92 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q4 2023.

Based on Allspring Global Investments's 13F filing for Q4 2023, filed 25 Jan 2024.